Case Report: Unusual persistent elevation of troponin I-systemic sclerosis masked by acute myocardial infarction
Lixia Zhang1, Shuqi Li2, Jinglei Niu1
1Heart Center, The First Hospital of Lanzhou University, Lanzhou, China.
Insights
This case report details a myocardial infarction (MI) in a patient with systemic sclerosis (SSc). Early diagnosis and tailored treatment led to significant patient improvement, offering insights into managing this rare comorbidity.
Area of Science:
- Cardiology
- Rheumatology
- Internal Medicine
Background:
- Myocardial infarction (MI) is a leading cause of death globally, stemming from coronary artery occlusion.
- Systemic sclerosis (SSc) is a rare autoimmune disease causing fibrosis and vascular issues, associated with high mortality.
- The co-occurrence of MI and SSc presents diagnostic and therapeutic challenges.
Abstract:
Myocardial infarction (MI) is a serious cardiovascular emergency that causes myocardial necrosis due to acute occlusion or spasm of a coronary artery leading to persistent ischemia and hypoxia; it is the major cause of death in patients with cardiovascular diseases worldwide. Systemic sclerosis (SSc) is a rare immune-mediated rheumatic disease characterized by fibrosis of skin and internal organs and vascular lesions. Although the survival in SSc has been improved in the past decades, the mortality rate remains high. Here we report a case of myocardial infarction combined with SSc and document the diagnostic and treatment process. A 55-year-old male patient underwent percutaneous coronary intervention (PCI) because of acute inferior MI, but a downtrend of cardiac troponin I (cTnI) was absent after operation. At 1 month later, the patient was readmitted for treatment due to residual vascular lesions, and the serum cTnI remained persistently high. After a thorough examination and histopathologic biopsy, the patient was ultimately diagnosed with a combination of SSc. Electrocardiograph, medical images, cardiac enzymes, and histopathological changes as well as coronary angiographic findings revealed the severity and complexity of the patient's condition. At 3 months after the second discharge, the follow-up data showed that the patient's condition improved significantly. This case may provide a novel perspective on the diagnosis and clinical management of this rare comorbidity.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiomyopathy IV: Restrictive Cardiomyopathy
